NCT06076122 is a NA clinical trial of Food supplement based on Salicornia extracts in Stroke, sponsored by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla.

Who is sponsoring NCT06076122?

NCT06076122 is sponsored by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla.

What drugs are being tested in NCT06076122?

Interventions in NCT06076122: Food supplement based on Salicornia extracts, Placebo.

What condition does NCT06076122 study?

NCT06076122 studies Stroke, Ischemic Stroke, Neurovascular Injury, Brain Ischemia.

Is NCT06076122 still recruiting?

NCT06076122 is currently status unknown. Last updated 10 October 2023.

Last reviewed 2023-10-10 · How we verify

NCT06076122

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Salicornia for Neurovascular Health Improve

Status unknown NA Last updated 10 October 2023

What this trial tests

NA trial testing Food supplement based on Salicornia extracts in Stroke in 350 participants. Status unknown.

Timeline

15 September 2022

Primary endpoint
9 February 2023

31 October 2023

Quick facts

Lead sponsor	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	350
Start date	15 September 2022
Primary completion	9 February 2023
Estimated completion	31 October 2023
Sites	1 location across Spain

Drugs / interventions tested

Food supplement based on Salicornia extracts
Placebo

Conditions studied

Stroke — all drugs for Stroke →
Ischemic Stroke — all drugs for Ischemic Stroke →
Neurovascular Injury — all drugs for Neurovascular Injury →
Brain Ischemia — all drugs for Brain Ischemia →

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla — full company profile →

Who can join

Adults 18 to 99, any sex, with Stroke or Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is evaluate the effect and safety of the administration of a food supplement based on halophyte plant extracts versus placebo in the neurovascular healthy.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Evaluating the Clinical Impact of a Polyphenol-Rich Extract from <i>Salicornia ramosissima</i> on Patients with Transient Ischemic Attack and Minor Stroke.
Nájar AM, López Azcárate C, Domínguez Ruiz C, Núñez-Jurado D, et al · · 2024 · cited 5× · PMID 39770931 · DOI 10.3390/nu16244307
11th European Stroke Organisation Conference Abstracts - 21-23 May 2025, Helsinki, Finland.
· 2025 · cited 3× · PMID 40726475 · DOI 10.1177/23969873251329993
Polyphenol-rich Salicornia extract in lacunar stroke: a pilot randomised trial of safety and exploratory clinical outcomes.
Pérez-Sánchez S, Del Río C, Núñez-Jurado D, Najar AM, et al · · 2026 · PMID 42160741 · DOI 10.1093/esj/aakag049
ABSTRACT NUMBER: ESOC2026A550 TARGETING POST-STROKE COGNITIVE IMPAIRMENT WITH A POLYPHENOL-RICH SALICORNIA EXTRACT
· 2026

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Fundación Pública Andaluza para la gestión de la Investigación en Sevilla trials

Trials by the same sponsor.

NCT05225961 — ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem · Phase 4 · completed
NCT07521969 — Out-patiente Management for Gangrenous Acute Appendicitis: The PENDI-CSI II Randomized Clinical Trial. · NA · recruiting
NCT07153406 — Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients · Phase 3 · not yet recruiting
NCT07353424 — A Multicenter Randomized Clinical Trial Compared With Standard Clinical Practice to Evaluate the Efficacy of a Polypheno · NA · recruiting
NCT06602310 — Utility of Preanestes@s2.0, a Web Based Application for Preoperative Assessment. · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06076122 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Last refreshed: 10 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06076122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing